Pfizer posted a third-quarter profit well ahead of analysts' estimates on higher sales of breast cancer drug Ibrance and raised its earnings forecast for the year, sending the largest U.S. drugmaker's shares up 3%.
from Earnings https://ift.tt/2MY3faZ
via IFTTT
No comments:
Post a Comment